ISSN: 2755-0117 | Open Access

Journal of Oncology Research Reviews & Reports

Anticancer, Anxiolytic, Nootropic Effects of Convolvulus Pluricaulis

Author(s): Rashmi Sharma

Abstract

Mental health disorders effect thinking, behave, mood etc. these can be schizophrenia, eating beh. Addictive beh, Depression, anxiety, feeling sad, down, fear, worry, guilt, anger, violence & suicidal thinking. Convolvulus is traditionally used to treat mental disorders insomnia, fatigue, low Energy

Introduction

Introduction Convolvulus is used in Ayurveda for mental stimulation & rejuvenation brain therapy.

Classification of Convolvulus
Kingdom: Plantae
Sub Kingdo: Viridiplantae.
Infra Kingdom: Streptophyta (Land plants)
Class: Dicotyledon
Family: Convolvulaceae
Order: Solanales
Genu: Convolvulus

Sub Species: Convolvulus prostrates var. deserti

Parts of a Plant: Root, Leaves, Stem flowers. All parts are of medicinal use.

Actions

Anti anxiety, Memory improver, anti oxidant, anti epileptic, anti convulsant, conc improver, memory improver, anti depressive, anti stress.

It is also Diuretic, Anti inflammatory, tonic for uterus, stimulates digestive system, carminative & Antacid, Aphrodisiac. Bitter, Unctuous, Cool, Sweet, Brain tonic, Effective in Hematemesis, Anorexia nervora. Hormonal changes, Neurotransmitter imbalance, Physical change in Brain can cause stress & depression, it has positive effects in brain chemical changes, balance is disturbed in Neurotransmitters, it increases Dopamine secretion & improves mental health, feel good. It also treats hypersensitivity, Autism, Attention Deficit Hyperactivity Disorder (ADHD), Headache, Overstress, mental load, overstudy, Dementia, memory loss, Mental fatigue, Hallucination, Moodiness, Dizziness, Indecisiveness, Anger, Vertigo, Mental fatigue, Excess sweating, Heat sensitivity, sense in head, Overwhelmed Irritability, restlessness, misc [1-10].

References

  1. Bharkatiya M, Goyal A, Gupta GD, Gaud RS (2006) Memory enhancers. Indian Pharmacist 5: 32 -36.
  2. Suba V, Murugesan T, Rao RB, Pal M, Mandal SC, Saha BP (2002) Neuropharmacological profile of Barleria lupulina Lindl . Extracts in animal models. J Ethnopharmacol 81: 251-255.
  3. Johnson N, Davis T, Bosanquet N (2000) the epidemic of Alzheimer’s disease. How can we manage the cost? disease Pharmacoeconomics 18: 215-223.
  4. Ordberg A, Sevensson AL (1998) Cholinesterase inhibiters in the treatment of Alzheimer s disease, a comparison of tolerability and pharmacology. Drug Saf 19: 465-480.
  5. Shah, Tangalas EG, Petersseen RC (2000) Mild cognitive impairments.When it is a precursor to Alzheimer diseases .Geriatrics 55: 65-68.
  6. Ukherjee PK, Kumar V, Mal M, Houghton PJ (2007) Acetylcholinesterase inhibitors from plants .Phytomedicine 14: 289-300.
  7. Ully T, Bourtchoula R, Scott R, Tallman J (2003) Targeting the CREB pathway for memory enhancres .Nat Rev Drug Discov 267-277.
  8. Anonymous Ministry of health and Family Welfare .Department of Indian systems of medicines and Homeopathy (M). The Ayurvedic pharmacopoeia of India: New Delhi: Controller of Publications 147-149.
  9. Shah V, Bole PV (1961) Botanical identity of Shankhpushpi. Indian J Pharm 23: 223-224.
  10. Austin DF (2008) Evolvulusalsinoides (Convolvulaceae) an American herb in old world. J. Ethnopharmacol 117: 185-198.
View PDF